TP-3654 Food Effect Study

Completed · Phase 1

Conditions studied: Myelofibroses

In brief

This clinical trial will determine the bioavailability and effect of food on TP-3654 in healthy adult participants.

Key facts

Study ID

NCT07492355

Run by

Sumitomo Pharma America, Inc.

People needed

24

Starts

2024-03-04

Expected to finish

2024-05-31

Last updated by the study team

2026-03-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participant has a BMI ≥ 18.5 and ≤ 32 kg/m2 at screening.
• Participant is generally healthy, as determined by the Investigator based on medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead ECG at screening.
• Participant agrees to avoid the use of concomitant medications (except hormonal contraception or medication provided by the site staff under the direction of the Investigator) from time of screening through the final follow-up visit.
• Participant agrees to abstain from alcohol, recreational drugs (including marijuana), and nicotine from time of screening through the final follow-up visit.
• Participant agrees to use acceptable method of contraception during the duration of the study and up to 6 months after last dose.
• Participant agrees to not donate eggs or sperm during the study and up to 6 months after last dose.

You may not qualify if…

• Pregnancy
• History of alcohol and recreational drug use including smoking and/or use of nicotine products.
• Clinically significant medical history
• Exposure to other investigational product

Where it is running

• Frontage Clinical — Secaucus, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.